Raymond James Financial’s IGM Biosciences IGMS Stock Holding History

Raymond James Financial’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,325	Closed	-$1.48K	–	5790
2025 Q2	$1.48K	Buy	+1,325	New	+$1.62K	﹤0.01%	6482

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Raymond James Financial's IGMS Position: Q3 2025 in Review

Raymond James Financial sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 1,325 shares — an estimated $1.48K sold.

Raymond James Financial first reported a position in IGMS in Q2 2025 and held it in 1 quarter. The position peaked at $1.48K in Q2 2025. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

Raymond James Financial reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 1,325 IGM Biosciences shares in Q3 2025, an estimated $1.48K.
Raymond James Financial first reported a position in IGM Biosciences in Q2 2025 and held it in 1 quarter.
Raymond James Financial's IGM Biosciences position peaked at $1.48K in Q2 2025.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.